# TROPION-Lung04 (NCT04612751)

> Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04612751
- Phase: PHASE1
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: AstraZeneca
- Conditions: Advanced or Metastatic NSCLC
- Interventions: Datopotamab deruxtecan; Durvalumab; Carboplatin; AZD2936; MEDI5752; AZD7789
- Enrollment: 155
- Primary outcome: Number of participants with DLTs; TEAEs and other safety parameters during the study.

## Commentary we found

- YouTube: 12
- X threads: 9
- Podcasts: 7

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=tropion-lung04-nct04612751

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04612751", "email": "<work email>"}; the inbox owner confirms by the emailed link.